Hemlibra 105 MG/0.7 ML vial 0.7ML
Ended Awarded
- Contract number
- SPE2DB25FY9BP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,168
Award facts
- Contract value 100% obligated
- $6,168.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of HEMLIBRA 105 mg/0.7 mL vials totaling $6,168.26. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award authority. The order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. HEMLIBRA is a specialty pharmaceutical product used in hemophilia treatment, reflecting the Defense Logistics Agency Medical Supply Chain's commitment to providing critical therapeutic medications to military healthcare systems and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor contract running through December 2026. The IDC enables the company to supply an extensive range of pharmaceuticals and medical supplies globally to support military healthcare programs, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's proven capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains positions it as a critical vendor within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FY9BP?
SPE2DB25FY9BP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FY9BP worth?
The government has obligated $6,168 on SPE2DB25FY9BP.
Is contract SPE2DB25FY9BP an order under another contract?
Yes. SPE2DB25FY9BP is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9BP competed?
The extent of competition for SPE2DB25FY9BP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award